AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 28 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $11,239,000 | +2.6% | 12,518,000 | -10.7% | 0.47% | -23.5% |
Q2 2020 | $10,957,000 | +32.1% | 14,018,000 | +30.2% | 0.61% | +44.7% |
Q1 2020 | $8,294,000 | -68.2% | 10,768,000 | -65.2% | 0.42% | -51.4% |
Q4 2019 | $26,051,000 | -9.6% | 30,963,000 | -11.7% | 0.87% | -17.3% |
Q3 2019 | $28,829,000 | +48.5% | 35,050,000 | +44.5% | 1.05% | +52.8% |
Q2 2019 | $19,409,000 | +123.1% | 24,250,000 | +142.5% | 0.68% | +158.5% |
Q1 2019 | $8,700,000 | – | 10,000,000 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 13,500,000 | $10,897,000 | 8.30% |
Context Capital Management, LLC | 11,400,000 | $9,153,000 | 5.31% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 36,525,000 | $29,507,000 | 1.49% |
WHITEBOX ADVISORS LLC | 24,250,000 | $19,409,000 | 0.68% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 30,000,000 | $23,854,000,000 | 0.46% |
IRON Financial LLC | 490,000 | $428,000 | 0.40% |
WOLVERINE ASSET MANAGEMENT LLC | 28,680,000 | $23,081,000 | 0.30% |
AQR Arbitrage LLC | 32,275,000 | $25,913,000 | 0.30% |
Telemetry Investments, L.L.C. | 300,000 | $240,000 | 0.18% |
CAPSTONE INVESTMENT ADVISORS, LLC | 9,500,000 | $7,627,000 | 0.06% |